# GeneDx Holdings Corp. (WGS) · Edgar & Edgarette company card

> GeneDx Holdings (WGS) grew revenue 40.0% in FY2025 to $428 million, operating margin -3.1%, in line with the -3.3% median for health services, equity 58.8% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1818331 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/WGS) · [JSON](https://www.pops4.com/boards/company/WGS.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $428M |
| Revenue growth, 1 year | 40.0% |
| Revenue growth per year | 19.1% |
| Operating margin | -3.1% (prior year -7.6%) |
| Net margin | -4.9% |
| Operating cash flow | $33M |
| Capital spending | $19M |
| Free cash flow | $14M |
| Cash | $105M |
| Long-term debt | $55M |
| Total assets | $524M |
| Total equity | $308M |
| Equity ÷ assets | 58.8% |
| Return on equity | -6.8% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -5.22 (distress zone)
- Piotroski F: 6 of 9 (solid)
- Beneish M: -2.36 (below the −1.78 line)
- Health Harbor boat: Weathered boat · two warning signs · operating loss: a margin of -3.1% in FY2025; revenue is hard to predict: its 80% range is ±31%
- Cash Compass: Cash cow later · growing fast, and already turning revenue into cash

## Edgarette's reading

Exposure: revenue $427.5M (FY2025), total debt $54.5M. Experience: revenue up 40.0% on the year, up 19.1% a year over 4 years; operating margin -3.1%, up from -7.6%. Soundness: equity 58.8% of assets, return on equity -6.8%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $401.9M and $755.2M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $342.7M to $891.6M. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, services-health services): operating margin -3.1% against a -3.3% median; growth 40.0% against 19.2%.

Range logged 2026-09-28, receipt c5c3c6ce30653cd9, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-11-18 ([filing](https://www.sec.gov/Archives/edgar/data/1818331/000110465926129358/0001104659-26-129358-index.htm))

## Recent filings

- 8-K · filed 2026-11-18 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1818331/000110465926129358/0001104659-26-129358-index.htm)
- 10-Q · filed 2026-11-09 · [filing](https://www.sec.gov/Archives/edgar/data/1818331/000162828026072203/0001628280-26-072203-index.htm)
- 8-K · filed 2026-11-09 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1818331/000162828026072172/0001628280-26-072172-index.htm)
- 10-Q · filed 2026-08-03 · [filing](https://www.sec.gov/Archives/edgar/data/1818331/000162828026051878/0001628280-26-051878-index.htm)
- 8-K · filed 2026-08-03 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1818331/000162828026051852/0001628280-26-051852-index.htm)
- 8-K · filed 2026-06-23 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1818331/000162828026044806/0001628280-26-044806-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001818331.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1818331

## Cite

POPS4, Edgar & Edgarette: GeneDx Holdings Corp. (WGS) company card, from the company's own SEC filings, accessed 2026-11-19, https://www.pops4.com/boards/company/WGS. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

